Alpha1-antitrypsin deficiency, cirrhosis and emphysema

Thorax

Volumn 53, Issue 6, 1998, Pages 501-505

  Mahadeva, Ravi ^a   Lomas, David A ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; LEUKOCYTE ELASTASE; POLYMER;

ALPHA 1 ANTITRYPSIN DEFICIENCY; CHRONIC LUNG DISEASE; DISEASE ASSOCIATION; ELECTRON MICROSCOPY; EMPHYSEMA; HUMAN; LIVER CIRRHOSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN CONFORMATION; REVIEW; THORAX RADIOGRAPHY; DIMERIZATION; GENETICS; GENOTYPE; LUNG EMPHYSEMA; METABOLISM; MUTATION; PHENOTYPE;

ALPHA 1-ANTITRYPSIN; ALPHA 1-ANTITRYPSIN DEFICIENCY; DIMERIZATION; GENOTYPE; HUMANS; LIVER CIRRHOSIS; MUTATION; PHENOTYPE; POLYMERS; PULMONARY EMPHYSEMA;

EID: 0032085755     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.53.6.501     Document Type: Review

References (61)

1. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1986;136:225-44.
2. Owen MC, Carrell RW. Alpha-1-antitrypsin: molecular abnormality of S variant. BMJ 1976;1:130-1.
3. 1-antitrypsin PiZ. FEBS Lett 1976;65:195-7.
4. 1-antitrypsin variant (Pi-ZZ) associated with plasma activity deficiency. Proc Natl Acad Sci USA 1976;73:1324-8.
5. Brantly M, Nukiwa T, Crystal RO. Molecular basis of alpha-1-antitrypsin deficiency. Am J Med 1988;84(Suppl 6A):13-31.
6. 1-antitrypsin deficiency detected by screening of 200,000 infants. N Engl J Med 1976;294:1316-21.
7. 1-antitrypsin deficiency. N Engl J Med 1986;314:736-9.
8. 1-antitrypsin deficient children. Acta Paediatr Scand 1988;77: 847-51.
9. 1-antitrypsin. Nature 1982;298:329-34.
10. 1-antitrypsin deficiency. Acta Med Scand 1965;Suppl 432:1-85.
11. 1-antitrypsin deficiency: evaluation of bronchiectasis with CT. Radiology 1996;199: 137-41.
12. Griffith ME, Lovegrove JU, Gaskin G, et al. C-antineutrophil cytoplasmic antibody positivity in vasculitis patients is associated with the Z allele of alpha-1-antitrypsin, and P-antineutrophil cytoplasmic antibody positivity with the S allele. Nephrol Dial Transplant 1996;11: 438-43.
13. Stein PD, Leu JD, Welsh MH, et al. Pathophysiology of the pulmonary circulation in emphysema associated with alpha-1 antitrypsin deficiency. Circulation 1971;43:227-39.
14. 1-antitrypsin for structure and function of serpins. Biochemistry 1989;28:8951-66.
15. Potempa J, Korzus E, Travis J. The serpin superfamily of proteinase inhibitors: structure, function, and regulation. J Biol Chem 1994;269:15957-60.
16. 1-antiplasmin, angiotensinogen, and ovalbumin. Biochemistry 1991;30:1723-30.
17. 1-antitrypsin. Nature Struct Biol 1996;3:676-81.
18. 1-antitrypsin is in the canonical inhibitory conformation. J Mol Biol 1998;275;419-125.
19. 1-antitrypsin by a peptide sequentially similar to β-strand s4A. Eur J Biochem 1990;194:51-6.
20. 1-proteinase inhibitor probed by limited proteolysis. Biochemistry 1992;31:2720-8.
21. 1-antitrypsin. Biochemistry 1993;32:500-8.
22. 1-antitrypsin. J Biol Chem 1995; 270:5282-88.
23. Patston PA, Hauert J, Michaud M, et al. Formation and properties of C1-inhibitor polymers. FEBS Lett 1995;368: 401-4.
24. 1-antitrypsin variant are degraded within the endoplasmic reticulum by a mechanism sensitive to inhibitors of protein synthesis. J Biol Chem 1992;267:1072-80.
25. 1-antitrypsin causes a protein folding defect. Nature Struct Biol 1995;2:363-7.
26. 1-antitrypsin accumulation in the liver. Nature 1992;357: 605-7.
27. 1-antitrypsin-deficient variant with mutation on a predicted conserved residue of the serpin backbone. J Biol Chem 1991;266: 12627-32.
28. Roberts EA, Cox DW, Medline A, et al. Occurrence of alpha-1-antitrypsin deficiency in 155 patients with alcoholic liver disease. Am J Clin Pathol 1984;82:424-7.
29. 53→Phe); further evidence for intracellular loop-sheet polymerisation. J Biol Chem 1993;268:15333-5.
30. 52Phe deleted) forms loop-sheet polymers in vivo: evidence for the C sheet mechanism of polymerisation. J Biol Chem 1995;270:16864-70.
31. 1-antitrypsin deficiency. Proc Natl Acad Sci USA 1994;91:9014-8.
32. 1-antitrypsin Z and S is distinct from that for an unassembled membrane protein. J Biol Chem 1996;271:13215-20.
33. Eldering E, Verpy E, Roem D, et al. COOH-terminal substitutions in the serpin C1 inhibitor that cause loop overinserrion and subsequent multimerization. J Biol Chem 1995; 270:2579-87.
34. Bruce D, Perry DJ, Borg J-Y, et al. Thromboembolic disease due to thermolabile conformational changes of antithrombin Rouen VI (187 Asn→Asp). J Clin Invest 1994;94: 2265-74.
35. Lindo VS, Kakkar W, Learmonth M, et al. Antithrombin-TRI (Ala382 to Thr) causing severe thromboembolic tendency undergoes the S-to-R transition and is associated with a plasma-inactive high-molecular-weight complex of aggregated antithrombin. Br J Haematol 1995;89:589-601.
36. 1-antichymotrypsin deficiency in a heterozygote with liver and lung disease. J Hepatol 1993;18:313-21.
37. 1-antichymotrypsin allele associated with familial obstructive lung disease. Genomics 1993;17:740-3.
38. 1-antitrypsin. Nature Struct Biol 1996;3:910-11.
39. 1-antitrypsin that confer enhancement in thermal stability. J Biol Chem 1994;269:9627-31.
40. 1-antitrypsin suppresses the folding defect of the Z-type variant. J Biol Chem 1995;270:8597-601.
41. 1-antitrypsin deficiency variants. J Biol Chem 1995;270:8393-6.
42. 1-antitrypsin at 2.7 Å. Structure 1996;4:1181-92.
43. Snider GL. Emphysema: the first two centuries - and beyond. A historical overview, with suggestions for future research. Am Rev Respir Dis 1992;146:1615-22.
44. 1-antitrypsin as an inhibitor of neutrophil elastase. J Clin Invest 1987;80: 1366-74.
45. 1-antitrypsin to prevent neutrophil mediated tissue damage. Biochim Biophys Acta 1994;1227:155-60.
46. Beatty K, Bieth J, Travis J. Kinetics of association of serine proteinases with native and oxidized α-1-proteinase inhibitor and α-1-antichymotrypsin. J Biol Chem 1980;255: 3931-4.
47. 1-proteinase inhibitor recovered from lungs of cigarette smokers contains oxidised methionine and has decreased elastase inhibitory capacity. Proc Natl Acad Sci USA 1982;79:2041-5.
48. 1-antitrypsin related emphysema. Am J Respir Cell Mol Biol (in press).
49. 1-proteinase inhibitor deficiency or chronic obstructive bronchitis: anti-elastase function and cell profile. Clin Sci 1987;72:373-81.
50. 1-antitrypsin deficiency, PiZ. Acta Med Scand 1978; 204:345-51.
51. 1-antitrypsin deficiency. Lancet 1985;i:152-4.
52. 1-protease inhibitor deficiency. Eur Respir J 1990;3(Suppl 9):29s-34s.
53. 1-antitrypsin deficiency associated with emphysema. N Engl J Med 1987;316:1055-62.
54. 1-antitrypsin variants of therapeutic potential for emphysema and thrombosis. Nature 1985;313:149-51.
55. 1-antitrypsin in dogs after autologous transplantation of retroviral transduced hepatocytes. Proc Natl Acad Sci USA 1992;89:89-93.
56. Jaffe HA, Danel C, Longenecker G, et al. Adenovirus-mediated in vivo gene transfer and expression in normal rat liver. Nature Genetics 1992;1:372-8.
57. 1-antitrypsin gene to the lung epithelium in vivo. Science 1991;252:431-4.
58. Massaro GD, Massaro D. Retinoic acid treatment abrogates elastase-induced pulmonary emphysema in rats. Nature Med 1997;3:675-7.
59. Carrell RW, Lomas DA. Conformational diseases. Lancet 1997;350:134-8.
60. Carrell RW, Stein PE, Fermi G, et al. Biological implications of a 3 Å structure of dimeric antithrombin. Structure 1994; 2:257-70.
61. Schreuder HA, de Boer B, Dijkema R, et al. The intact and cleaved human antithrombin III complex as a model for serpin-proteinase interactions. Nature Struct Biol 1994;1: 48-54.